Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study have?
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study has 2,563 citations in the OpenAlex counts ScholarIQ stores.
When was Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study published?
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study has 2010 year in the ScholarIQ index.
What is the open-access status of Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study?
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study has green oa status in the ScholarIQ index.
What is the DOI of Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study?
The DOI for Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study is on the source record.
What is the PMID of Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study?
The PMID for Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study is on the source record.
What is the OpenAlex record for Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study?
The OpenAlex for Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study is on the source record.